Although most TADs maintained their structure after decitabine treatment, their boundaries became less insulated, with no significant change in CTCF occupancy at the altered TAD boundaries, suggesting increased intra-tumor heterogeneity in TAD structure and loss of some TAD boundaries at the regions of chromosomal compartment de-compaction. Here, CTCF is linked to neoplasm.